GLIOLAN
Ácido 5-aminolevulínico
O RESPONSÁVEL NÃO FORNECEU MAIS INFORMAÇÃO
CONSULTE AS SEGUINTES ALTERNATIVAS:
Resumo de Grupo do GLIOLAN
16) MEDICAMENTOS ANTINEOPLÁSICOS E IMUNOMODULADORES; 1) CITOTÓXICOS; 9) Outros citotóxicos
SIMILARES QUÍMICOS DO GLIOLAN
(Ácido 5-aminolevulínico)
Não disponível
SIMILARES TERAPÊUTICOS DO GLIOLAN
Alpelisib
Ø PIQRAY | NOVARTIS EUROPHARM | |
---|---|---|
56 comp. rev. p/pel. (50 mg) + (200 mg) ‐[0%], [ PVP €0.00 ] | ||
28 comp. rev. p/pel. 200 mg ‐[0%], [ PVP €0.00 ] |
Aminolevulinato de metilo
Ø METVIX | GALDERMA | |
---|---|---|
1 bis. 2 g cr. (160 mg/g) ‐[0%], [ PVP €0.00 ] |
Axicabtagene ciloleucel
Ø YESCARTA | KITE PHARMA | |
---|---|---|
1 saco 68 ml dispers. p/perf. 0.4 - 2 x10e8 células ‐[0%], [ PVP €0.00 ] |
Bexaroteno
Ø TARGRETIN | EISAI | |
---|---|---|
100 cáps. moles 75 mg ‐[0%], [ PVP €931.72 ] |
Bortezomib
Ø ¥ BORTEZOMIB ACCORD | ACCORD | |
---|---|---|
1 fr. p/inj. pó p/sol inj. 3,5 mg ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. 1,4 ml sol. inj. (2.5 mg/ml) ‐[0%], [ PVP €0.00 ] |
Ø ¥ BORTEZOMIB BAXTER | BAXTER | |
---|---|---|
1 fr. p/inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ BORTEZOMIB FRESENIUS KABI | FRESENIUS KABI DEUTSCHLAND | |
---|---|---|
1 fr. p/inj. pó p/sol. inj. 2,5 mg ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ BORTEZOMIB GENERIS | EUGIA PHARMA | |
---|---|---|
1 fr. p/inj. pó p/sol. inj. 3,5 MG ‐[0%], [ PVP €0.00 ] |
Ø ¥ BORTEZOMIB HIKMA | HIKMA | |
---|---|---|
1 fr. p/inj. pó p/sol. inj. (3.5 mg) ‐[0%], [ PVP €0.00 ] |
Ø ¥ BORTEZOMIB MYLAN | MYLAN | |
---|---|---|
1 fr. p/inj. pó p/sol. inj. 3.5 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ BORTEZOMIB REDDY | REDDY HOLDING | |
---|---|---|
1 fr. p/ inj. pó p/sol. inj. 3,5 mg ‐[0%], [ PVP €0.00 ] |
Ø BORTEZOMIB STADA | STADA | |
---|---|---|
1 fr. p/inj. 1,4 ml sol. inj. (2.5 mg/ml) ‐[0%], [ PVP €0.00 ] |
Carfilzomib
Ø KYPROLIS | AMGEN | |
---|---|---|
1 fr. p/inj. pó p/sol. p/perf. 60 mg ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. pó p/sol. p/perf. 10 mg ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. pó p/sol. p/perf. 30 mg ‐[0%], [ PVP €0.00 ] |
Crisantaspase (Asparaginase)
Ø ¥ ERWINASE [MG] | PORTON BIOPHARMA | |
---|---|---|
5 frs. p/inj. pó p/sol. inj. ou p/perf. 10000 U.I. ‐[0%], [ PVP €0.00 ] |
Dicloreto de rádio (223Ra)
Ø XOFIGO | BAYER | |
---|---|---|
1 fr. p/inj. 6 ml sol. inj. (1.100 kBq/ml) ‐[0%], [ PVP €0.00 ] |
Entrectinib
Ø ROZLYTREK | ROCHE | |
---|---|---|
30 cáps. 100 mg ‐[0%], [ PVP €0.00 ] | ||
90 cáps. 200 mg ‐[0%], [ PVP €0.00 ] |
Erlotinib
Ø ¥ ERLOTINIB MYLAN | MYLAN | |
---|---|---|
30 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pel. 25 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ ERLOTINIB QRITOU | TEVA B.V. | |
---|---|---|
30 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pel. 25 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ ERLOTINIB SANDOZ | SANDOZ | |
---|---|---|
30 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pel. 25 mg ‐[0%], [ PVP €0.00 ] |
Ø TARCEVA | ROCHE | |
---|---|---|
30 comp. rev. p/pelíc. 100 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pelíc. 150 mg ‐[0%], [ PVP €0.00 ] | ||
30 comp. rev. p/pelíc. 25 mg ‐[0%], [ PVP €0.00 ] |
Glofitamab
Ø COLUMVI | ROCHE | |
---|---|---|
1 fr. p/inj. 10 ml conc. p/sol. p/perf. (10 mg/10 ml) ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. 2,5 ml conc. p/sol. p/perf. (2,5 mg/2,5 ml) ‐[0%], [ PVP €0.00 ] |
Hidroxicarbamida
Ø ¥ HIDROXICARBAMIDA HIKMA | HIKMA | |
---|---|---|
100 cáps. 500 mg ‐[0%], [ PVP €0.00 ] |
Ø HYDROXYUREA MEDAC | MEDAC | |
---|---|---|
100 cáps. 500 mg ‐[0%], [ PVP €0.00 ] |
Ø SIKLOS | ROVI (Theravia) | |
---|---|---|
60 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €104.46 ] |
Idelalisib
Ø ZYDELIG | GILEAD | |
---|---|---|
60 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] | ||
60 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ] |
Ixazomib
Ø NINLARO | TAKEDA PHARMA | |
---|---|---|
3 cáps. 2,3 mg ‐[0%], [ PVP €0.00 ] | ||
3 cáps. 3 mg ‐[0%], [ PVP €0.00 ] | ||
3 cáps. 4 mg ‐[0%], [ PVP €0.00 ] |
Lutécio (177Lu) vipivotido tetraxetano
Ø PLUVICTO | NOVARTIS EUROPHARM | |
---|---|---|
1 fr. p/inj. 7,5 ml sol. inj. ou p/perf. 1000 MBq/ml ‐[0%], [ PVP €0.00 ] |
Mitotano
Ø LYSODREN | HRA PHARMA | |
---|---|---|
100 comp. 500 mg ‐[0%], [ PVP €0.00 ] |
Niraparib
Ø ZEJULA Comprimidos | GLAXOSMITHKLINE | |
---|---|---|
56 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] |
Olaparib
Ø LYNPARZA Comprimidos | ASTRAZENECA AB | |
---|---|---|
56 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] | ||
56 comp. rev. p/pel. 150 mg ‐[0%], [ PVP €0.00 ] |
Oxodotreótido de lutécio (177Lu)
Ø LUTATHERA | ADVANCED ACCELERATOR | |
---|---|---|
1 fr. p/inj. sol. p/perf. (370 MBq/ml) ‐[0%], [ PVP €0.00 ] |
Pegaspargase
Ø ONCASPAR Pó para solução injetável ou para perfusão | SERVIER | |
---|---|---|
1 fr. p/inj. pó p/sol. inj. ou p/perf. 3750 U ‐[0%], [ PVP €0.00 ] |
Ramucirumab
Ø CYRAMZA | ELI LILLY | |
---|---|---|
1 fr. 50 ml conc. p/sol. p/perf. (10 mg/ml) ‐[0%], [ PVP €0.00 ] | ||
1 fr. 10 ml conc. p/sol. p/perf. (10 mg/ml) ‐[0%], [ PVP €0.00 ] |
Sorafenib
Ø NEXAVAR | BAYER | |
---|---|---|
112 comp. rev. p/pelíc. 200 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ SORAFENIB ACCORD | ACCORD | |
---|---|---|
112 comp. rev. p/pel. em dose unitária 200 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ SORAFENIB STADA | STADA | |
---|---|---|
112 comp. rev. p/pel. 200 mg ‐[0%], [ PVP €0.00 ] |
Ø ¥ SORAFENIB TEVA | TEVA PHARMA | |
---|---|---|
112 comp. rev. p/pel. 200 mg ‐[0%], [ PVP €0.00 ] |
Talazoparib
Ø TALZENNA | PFIZER | |
---|---|---|
30 cáps. 0.25 mg ‐[0%], [ PVP €0.00 ] | ||
30 cáps. 1 mg ‐[0%], [ PVP €0.00 ] |
Teclistamab
Ø TECVAYLI | JANSSEN-CILAG | |
---|---|---|
1 fr. p/inj. sol inj. 10 mg/ml ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. sol inj. 90 mg/ml ‐[0%], [ PVP €0.00 ] |
Trabectedina
Ø ¥ TRABECTEDINA TEVA | TEVA B.V. | |
---|---|---|
1 fr. p/inj. pó p/conc. p/sol. p/perf. 0,25 mg ‐[0%], [ PVP €0.00 ] | ||
1 fr. p/inj. pó p/conc. p/sol. p/perf. 1 mg ‐[0%], [ PVP €0.00 ] |
Ø YONDELIS | PHARMA MAR | |
---|---|---|
1 fr. pó p/conc. p/sol. p/perf. 0,25 mg ‐[0%], [ PVP €0.00 ] | ||
1 fr. pó p/conc. p/sol. p/perf. 1 mg ‐[0%], [ PVP €0.00 ] |
Tremelimumab
Ø IMJUDO | ASTRAZENECA AB | |
---|---|---|
1 fr. 15 ml conc. p/sol. p/perf. (20 mg/ml) ‐[0%], [ PVP €0.00 ] |
Tretinoína (ou Ácido retinóico)
Ø VESANOID | CHEPLAPHARM | |
---|---|---|
100 cáps. moles 10 mg ‐[0%], [ PVP €0.00 ] |
Trióxido de arsénio
Ø ¥ TRIÓXIDO DE ARSÉNIO GENERIS | EUGIA PHARMA | |
---|---|---|
10 amp. 10 ml conc. p/sol. p/perf. ( mg/ml) ‐[0%], [ PVP €0.00 ] |
Ø ¥ TRIÓXIDO DE ARSÉNIO MYLAN | MYLAN | |
---|---|---|
10 frs. p/inj. 10 ml conc. p/sol. p/perf. (1 mg/ml) ‐[0%], [ PVP €0.00 ] |
Venetoclax
Ø VENCLYXTO | ABBVIE | |
---|---|---|
14 comp. rev. p/pel. 10 mg ‐[0%], [ PVP €0.00 ] | ||
7 comp. rev. p/pel. 100 mg ‐[0%], [ PVP €0.00 ] | ||
7 comp. rev. p/pel. 50 mg ‐[0%], [ PVP €0.00 ] |
Vismodegib
Ø ERIVEDGE | ROCHE | |
---|---|---|
28 cáps. 150 mg ‐[0%], [ PVP €0.00 ] |